Clinical Trial Update: Safety of SonoVue on Pulmonary Hemodynamics [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety of the SonoVue ultrasound contrast agent on pulmonary hemodynamics in patients with pulmonary hypertension; results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pulmonary Hypertension

Drugs mentioned

• SonoVue (sulfur hexafluoride microbubbles)

Snippet

Sponsor: Bracco Diagnostics, Inc | Conditions: Pulmonary Hypertension | Phase 2 | Status: COMPLETED | Results posted: 2016-02-08